Company Monitoring Page for Sutro-BioPharma

latest headlines for company on cafepharma

Ipsen joins ADC race via $900M biobuck deal with Sutro, chasing same target as Merck, Boehringer
Fierce Biotech
Tue, 04/2/24 - 11:34 am
Tags:
Ipsen, antibody-drug conjugate, Sutro BioPharma
Sutro strengthens its immuno-oncology pipeline with two new ADCs
Clinical Trials Arena
Fri, 08/11/23 - 10:03 am
Tags:
Sutro BioPharma, immuno-oncology, antibody-drug conjugate
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Tags:
Aldeyra Therapeutics, Autolus Therapeutics, Bavarian Nordic, BioXcel Therapeutics, Disc Medicine, Editas Medicine, Immunogen, Lantheus, Mersana Therapeutics, NGM Biopharmaceuticals, Omeros, Roche, Sutro BioPharma, uniQure, Valneva, Viking Therapeutics
Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial
Endpoints
Tue, 01/10/23 - 10:54 am
Tags:
Sutro BioPharma, clinical trials, antibody-drug conjugate, ovarian cancer, luveltamab tazevibulin
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Tags:
Astellas, Sutro BioPharma, antibody-drug conjugate, cancer, immuno-oncology
Biopharma developments over the Christmas period
EP Vantage
Mon, 01/3/22 - 10:26 am
Tags:
Alnylam Pharmaceuticals, Bio-Thera Solutions, BioArctic, Biogen, BridgeBio Pharma, Daiichi Sankyo, Eisai, JNJ, Madrigal Pharmaceuticals, Merck, Sutro BioPharma, Tasly Pharmaceutical Group
Sutro bucks the folate trend
EP Vantage
Fri, 12/4/20 - 10:50 am
Tags:
Sutro BioPharma, STRO-002
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Tags:
Adamis Pharmaceuticals, Redhill Biopharma, Amag Pharmaceuticals, Arqule, Agile Therapeutics, Agios Pharmaceuticals, Deciphera, Mirati Therapeutics, Sutro BioPharma, Merck, Pfizer, Amgen, EXACT Sciences, Bristol-Myers Squibb, Celgene, Oyster Point Pharma
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
Tags:
ADA, Merck, Keytruda, NGM Biopharmaceuticals, NGM313/MK-3655, Corbus Pharmaceuticals, Nektar, Galapagos, Kezar Life Sciences, Kura Oncology, Bluebird Bio, BeiGene, Global Blood Therapeutics, Blueprint Medicines, Regeneron, Arqule, Sunesis, Sutro BioPharma, Incyte, Geron, Forty Seven
Nasdaq triple IPO play brings in $345M as the big biotech party rocks on
Endpoints
Thu, 09/27/18 - 11:55 am
Tags:
NASDAQ, IPOs, Entasis, Urovant Sciences, Arvinas, Sutro BioPharma
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Forbes
Wed, 09/19/18 - 11:31 am
Tags:
biotech, IPOs, immuno-oncology, Gritstone Oncology, Sutro BioPharma
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
Xconomy
Thu, 08/30/18 - 11:46 pm
Tags:
biotech, IPOs, Sutro BioPharma, Arvinas, cancer
Days after Merck deal, Sutro rolls out $85M E round to fund internal cancer pipeline
Endpoints
Thu, 07/26/18 - 07:05 pm
Tags:
Sutro BioPharma, cancer, Merck

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.